Skip to Main Content

Paper Details

Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients ⿥65 years old.
Muscle Nerve
6
2021
Author NameAffiliation
Anthony A AmatoBrigham and Women's Hospital
Anthony A AmatoHarvard Medical School
  • 1 - 2

Datasets

Release 1.2